DD280323A5 - Herstellung von zwischenprodukten der oxophthalazinyl-essigsaeuren mit benzothiazol- oder anderen heterocyclischen seitenketten - Google Patents

Herstellung von zwischenprodukten der oxophthalazinyl-essigsaeuren mit benzothiazol- oder anderen heterocyclischen seitenketten Download PDF

Info

Publication number: DD280323A5
Authority: DD; German Democratic Republic
Prior art keywords: formula; compound; oxo; phthalazin; mixture
Prior art date: 1987-06-09

Application number

DD88326850A

Other languages

German (de)

English (en)

Inventor

Banavara L Mylari

William J Zembrowski

Original Assignee

��@��Kk��

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1987-06-09

Filing date

1988-06-07

Publication date

1990-07-04

1988-06-07 Application filed by ��@��Kk�� filed Critical ��@��Kk��

1990-07-04 Publication of DD280323A5 publication Critical patent/DD280323A5/de

Links

IOJUPLGTWVMSFF-UHFFFAOYSA-N benzothiazole Chemical compound C1=CC=C2SC=NC2=C1 IOJUPLGTWVMSFF-UHFFFAOYSA-N 0.000 title abstract description 6
238000002360 preparation method Methods 0.000 title description 5
239000013067 intermediate product Substances 0.000 title description 2
239000007991 ACES buffer Substances 0.000 title 1
239000001257 hydrogen Substances 0.000 claims abstract description 14
229910052739 hydrogen Inorganic materials 0.000 claims abstract description 14
239000000460 chlorine Substances 0.000 claims abstract description 6
229910052794 bromium Inorganic materials 0.000 claims abstract description 5
229910052801 chlorine Inorganic materials 0.000 claims abstract description 5
125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims abstract description 5
WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 claims abstract description 4
ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 claims abstract description 4
PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 claims abstract description 4
GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 claims abstract description 4
239000011737 fluorine Substances 0.000 claims abstract description 4
229910052731 fluorine Inorganic materials 0.000 claims abstract description 4
125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims abstract description 4
150000001875 compounds Chemical class 0.000 claims description 73
238000000034 method Methods 0.000 claims description 29
125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 4
125000000217 alkyl group Chemical group 0.000 claims description 3
125000003545 alkoxy group Chemical group 0.000 claims 1
239000002253 acid Substances 0.000 abstract description 36
UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract description 6
239000000543 intermediate Substances 0.000 abstract description 5
150000002431 hydrogen Chemical class 0.000 abstract description 4
125000000623 heterocyclic group Chemical group 0.000 abstract description 2
125000004768 (C1-C4) alkylsulfinyl group Chemical group 0.000 abstract 1
125000004769 (C1-C4) alkylsulfonyl group Chemical group 0.000 abstract 1
150000007513 acids Chemical class 0.000 abstract 1
238000004519 manufacturing process Methods 0.000 abstract 1
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 33
239000000243 solution Substances 0.000 description 23
239000000203 mixture Substances 0.000 description 22
239000002904 solvent Substances 0.000 description 20
ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 19
UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 18
KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 18
238000006243 chemical reaction Methods 0.000 description 18
239000007787 solid Substances 0.000 description 17
WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 16
XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 15
VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 15
239000011541 reaction mixture Substances 0.000 description 14
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 14
150000003839 salts Chemical class 0.000 description 13
YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 12
-1 alkali metal alkoxides Chemical class 0.000 description 11
IXCSERBJSXMMFS-UHFFFAOYSA-N hydrogen chloride Substances Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 description 11
229910000041 hydrogen chloride Inorganic materials 0.000 description 11
238000010992 reflux Methods 0.000 description 10
OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 9
YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 9
125000004494 ethyl ester group Chemical group 0.000 description 9
239000005457 ice water Substances 0.000 description 8
239000000047 product Substances 0.000 description 8
YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 8
QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 7
125000004093 cyano group Chemical group *C#N 0.000 description 7
RENMDAKOXSCIGH-UHFFFAOYSA-N Chloroacetonitrile Chemical compound ClCC#N RENMDAKOXSCIGH-UHFFFAOYSA-N 0.000 description 6
HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 6
WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 6
HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 6
LMBFAGIMSUYTBN-MPZNNTNKSA-N teixobactin Chemical compound C([C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H](CCC(N)=O)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H]1C(N[C@@H](C)C(=O)N[C@@H](C[C@@H]2NC(=N)NC2)C(=O)N[C@H](C(=O)O[C@H]1C)[C@@H](C)CC)=O)NC)C1=CC=CC=C1 LMBFAGIMSUYTBN-MPZNNTNKSA-N 0.000 description 6
RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 5
238000009835 boiling Methods 0.000 description 5
238000004587 chromatography analysis Methods 0.000 description 5
239000002244 precipitate Substances 0.000 description 5
CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 4
239000004215 Carbon black (E152) Substances 0.000 description 4
OAKJQQAXSVQMHS-UHFFFAOYSA-N Hydrazine Chemical compound NN OAKJQQAXSVQMHS-UHFFFAOYSA-N 0.000 description 4
239000002585 base Substances 0.000 description 4
125000001246 bromo group Chemical group Br* 0.000 description 4
125000001309 chloro group Chemical group Cl* 0.000 description 4
229930195733 hydrocarbon Natural products 0.000 description 4
150000002430 hydrocarbons Chemical class 0.000 description 4
238000011065 in-situ storage Methods 0.000 description 4
125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 4
NNFCIKHAZHQZJG-UHFFFAOYSA-N potassium cyanide Chemical compound [K+].N#[C-] NNFCIKHAZHQZJG-UHFFFAOYSA-N 0.000 description 4
LPNYRYFBWFDTMA-UHFFFAOYSA-N potassium tert-butoxide Chemical compound [K+].CC(C)(C)[O-] LPNYRYFBWFDTMA-UHFFFAOYSA-N 0.000 description 4
JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 4
238000005160 1H NMR spectroscopy Methods 0.000 description 3
PHSPJQZRQAJPPF-UHFFFAOYSA-N N-alpha-Methylhistamine Chemical compound CNCCC1=CN=CN1 PHSPJQZRQAJPPF-UHFFFAOYSA-N 0.000 description 3
LGRFSURHDFAFJT-UHFFFAOYSA-N Phthalic anhydride Natural products C1=CC=C2C(=O)OC(=O)C2=C1 LGRFSURHDFAFJT-UHFFFAOYSA-N 0.000 description 3
VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 3
FIAGYDIJZOWVAB-UHFFFAOYSA-N [2-sulfanyl-5-(trifluoromethyl)phenyl]azanium;chloride Chemical compound Cl.NC1=CC(C(F)(F)F)=CC=C1S FIAGYDIJZOWVAB-UHFFFAOYSA-N 0.000 description 3
229910052783 alkali metal Inorganic materials 0.000 description 3
JHIWVOJDXOSYLW-UHFFFAOYSA-N butyl 2,2-difluorocyclopropane-1-carboxylate Chemical compound CCCCOC(=O)C1CC1(F)F JHIWVOJDXOSYLW-UHFFFAOYSA-N 0.000 description 3
238000001816 cooling Methods 0.000 description 3
TVZPLCNGKSPOJA-UHFFFAOYSA-N copper zinc Chemical compound [Cu].[Zn] TVZPLCNGKSPOJA-UHFFFAOYSA-N 0.000 description 3
150000008282 halocarbons Chemical class 0.000 description 3
VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
125000001624 naphthyl group Chemical group 0.000 description 3
150000007524 organic acids Chemical class 0.000 description 3
239000012074 organic phase Substances 0.000 description 3
125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 3
229910000027 potassium carbonate Inorganic materials 0.000 description 3
NLKNQRATVPKPDG-UHFFFAOYSA-M potassium iodide Chemical compound [K+].[I-] NLKNQRATVPKPDG-UHFFFAOYSA-M 0.000 description 3
239000000741 silica gel Substances 0.000 description 3
229910002027 silica gel Inorganic materials 0.000 description 3
QCQCHGYLTSGIGX-GHXANHINSA-N 4-[[(3ar,5ar,5br,7ar,9s,11ar,11br,13as)-5a,5b,8,8,11a-pentamethyl-3a-[(5-methylpyridine-3-carbonyl)amino]-2-oxo-1-propan-2-yl-4,5,6,7,7a,9,10,11,11b,12,13,13a-dodecahydro-3h-cyclopenta[a]chrysen-9-yl]oxy]-2,2-dimethyl-4-oxobutanoic acid Chemical compound N([C@@]12CC[C@@]3(C)[C@]4(C)CC[C@H]5C(C)(C)[C@@H](OC(=O)CC(C)(C)C(O)=O)CC[C@]5(C)[C@H]4CC[C@@H]3C1=C(C(C2)=O)C(C)C)C(=O)C1=CN=CC(C)=C1 QCQCHGYLTSGIGX-GHXANHINSA-N 0.000 description 2
206010007749 Cataract diabetic Diseases 0.000 description 2
208000032131 Diabetic Neuropathies Diseases 0.000 description 2
206010012689 Diabetic retinopathy Diseases 0.000 description 2
JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
238000006680 Reformatsky reaction Methods 0.000 description 2
UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
WQDUMFSSJAZKTM-UHFFFAOYSA-N Sodium methoxide Chemical compound [Na+].[O-]C WQDUMFSSJAZKTM-UHFFFAOYSA-N 0.000 description 2
HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 2
150000001243 acetic acids Chemical class 0.000 description 2
230000001476 alcoholic effect Effects 0.000 description 2
150000001340 alkali metals Chemical class 0.000 description 2
230000001684 chronic effect Effects 0.000 description 2
239000012230 colorless oil Substances 0.000 description 2
239000012043 crude product Substances 0.000 description 2
206010012601 diabetes mellitus Diseases 0.000 description 2
201000007025 diabetic cataract Diseases 0.000 description 2
PQJJJMRNHATNKG-UHFFFAOYSA-N ethyl bromoacetate Chemical compound CCOC(=O)CBr PQJJJMRNHATNKG-UHFFFAOYSA-N 0.000 description 2
238000001704 evaporation Methods 0.000 description 2
230000008020 evaporation Effects 0.000 description 2
239000000284 extract Substances 0.000 description 2
229910052500 inorganic mineral Inorganic materials 0.000 description 2
238000002844 melting Methods 0.000 description 2
230000008018 melting Effects 0.000 description 2
239000011707 mineral Substances 0.000 description 2
235000010755 mineral Nutrition 0.000 description 2
230000007823 neuropathy Effects 0.000 description 2
239000012071 phase Substances 0.000 description 2
FAIAAWCVCHQXDN-UHFFFAOYSA-N phosphorus trichloride Chemical compound ClP(Cl)Cl FAIAAWCVCHQXDN-UHFFFAOYSA-N 0.000 description 2
239000003880 polar aprotic solvent Substances 0.000 description 2
239000000725 suspension Substances 0.000 description 2
NWZSZGALRFJKBT-KNIFDHDWSA-N (2s)-2,6-diaminohexanoic acid;(2s)-2-hydroxybutanedioic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O.NCCCC[C@H](N)C(O)=O NWZSZGALRFJKBT-KNIFDHDWSA-N 0.000 description 1
ZEDQLIHBPGNGEC-UHFFFAOYSA-N 2-(4-oxo-3h-phthalazin-1-yl)acetic acid Chemical compound C1=CC=C2C(CC(=O)O)=NNC(=O)C2=C1 ZEDQLIHBPGNGEC-UHFFFAOYSA-N 0.000 description 1
YXRHEUYEOGNXIY-UHFFFAOYSA-N 2-amino-4,6-difluorobenzenethiol;hydrochloride Chemical compound Cl.NC1=CC(F)=CC(F)=C1S YXRHEUYEOGNXIY-UHFFFAOYSA-N 0.000 description 1
REXUYBKPWIPONM-UHFFFAOYSA-N 2-bromoacetonitrile Chemical group BrCC#N REXUYBKPWIPONM-UHFFFAOYSA-N 0.000 description 1
GNHMRTZZNHZDDM-UHFFFAOYSA-N 3-chloropropionitrile Chemical compound ClCCC#N GNHMRTZZNHZDDM-UHFFFAOYSA-N 0.000 description 1
102000016912 Aldehyde Reductase Human genes 0.000 description 1
108010053754 Aldehyde reductase Proteins 0.000 description 1
CXFHMSJQWOIZBA-UHFFFAOYSA-N C(C)(=O)OC1=NN(C(C2=CC=CC=C12)=O)CC#N Chemical compound C(C)(=O)OC1=NN(C(C2=CC=CC=C12)=O)CC#N CXFHMSJQWOIZBA-UHFFFAOYSA-N 0.000 description 1
DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 1
PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
REIQQFZDOIRQRJ-UHFFFAOYSA-N [2-sulfanyl-4-(trifluoromethyl)phenyl]azanium;chloride Chemical compound Cl.NC1=CC=C(C(F)(F)F)C=C1S REIQQFZDOIRQRJ-UHFFFAOYSA-N 0.000 description 1
QTBSBXVTEAMEQO-UHFFFAOYSA-N acetic acid Substances CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 1
235000011054 acetic acid Nutrition 0.000 description 1
239000003288 aldose reductase inhibitor Substances 0.000 description 1
229940090865 aldose reductase inhibitors used in diabetes Drugs 0.000 description 1
229910000288 alkali metal carbonate Inorganic materials 0.000 description 1
150000008041 alkali metal carbonates Chemical class 0.000 description 1
229910000102 alkali metal hydride Inorganic materials 0.000 description 1
150000008046 alkali metal hydrides Chemical class 0.000 description 1
150000008044 alkali metal hydroxides Chemical class 0.000 description 1
229910052784 alkaline earth metal Inorganic materials 0.000 description 1
125000004390 alkyl sulfonyl group Chemical group 0.000 description 1
SOIFLUNRINLCBN-UHFFFAOYSA-N ammonium thiocyanate Chemical compound [NH4+].[S-]C#N SOIFLUNRINLCBN-UHFFFAOYSA-N 0.000 description 1
239000006286 aqueous extract Substances 0.000 description 1
239000008346 aqueous phase Substances 0.000 description 1
239000007864 aqueous solution Substances 0.000 description 1
150000004945 aromatic hydrocarbons Chemical class 0.000 description 1
125000003118 aryl group Chemical group 0.000 description 1
125000005605 benzo group Chemical group 0.000 description 1
230000037396 body weight Effects 0.000 description 1
SSOVHFPWMPUQOS-UHFFFAOYSA-N cyanomethyl benzenesulfonate Chemical compound N#CCOS(=O)(=O)C1=CC=CC=C1 SSOVHFPWMPUQOS-UHFFFAOYSA-N 0.000 description 1
150000004292 cyclic ethers Chemical class 0.000 description 1
150000001983 dialkylethers Chemical class 0.000 description 1
SDIXRDNYIMOKSG-UHFFFAOYSA-L disodium methyl arsenate Chemical compound [Na+].[Na+].C[As]([O-])([O-])=O SDIXRDNYIMOKSG-UHFFFAOYSA-L 0.000 description 1
238000006073 displacement reaction Methods 0.000 description 1
238000001035 drying Methods 0.000 description 1
150000002148 esters Chemical class 0.000 description 1
NLFBCYMMUAKCPC-KQQUZDAGSA-N ethyl (e)-3-[3-amino-2-cyano-1-[(e)-3-ethoxy-3-oxoprop-1-enyl]sulfanyl-3-oxoprop-1-enyl]sulfanylprop-2-enoate Chemical compound CCOC(=O)\C=C\SC(=C(C#N)C(N)=O)S\C=C\C(=O)OCC NLFBCYMMUAKCPC-KQQUZDAGSA-N 0.000 description 1
AYSNDQRTQJFNTG-UHFFFAOYSA-N ethyl 2-(1-hydroxy-3-oxo-2-benzofuran-1-yl)acetate Chemical compound C1=CC=C2C(CC(=O)OCC)(O)OC(=O)C2=C1 AYSNDQRTQJFNTG-UHFFFAOYSA-N 0.000 description 1
XBIOFKSFKYRIIX-UHFFFAOYSA-N ethyl 2-(4-oxo-3h-phthalazin-1-yl)acetate Chemical compound C1=CC=C2C(CC(=O)OCC)=NNC(=O)C2=C1 XBIOFKSFKYRIIX-UHFFFAOYSA-N 0.000 description 1
JMIAPORGEDIDLT-UHFFFAOYSA-N ethyl ethanimidate Chemical compound CCOC(C)=N JMIAPORGEDIDLT-UHFFFAOYSA-N 0.000 description 1
WBJINCZRORDGAQ-UHFFFAOYSA-N ethyl formate Chemical compound CCOC=O WBJINCZRORDGAQ-UHFFFAOYSA-N 0.000 description 1
239000000706 filtrate Substances 0.000 description 1
238000001914 filtration Methods 0.000 description 1
239000007789 gas Substances 0.000 description 1
229910052736 halogen Inorganic materials 0.000 description 1
150000002367 halogens Chemical class 0.000 description 1
IKDUDTNKRLTJSI-UHFFFAOYSA-N hydrazine monohydrate Substances O.NN IKDUDTNKRLTJSI-UHFFFAOYSA-N 0.000 description 1
230000007062 hydrolysis Effects 0.000 description 1
238000006460 hydrolysis reaction Methods 0.000 description 1
125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
239000003112 inhibitor Substances 0.000 description 1
239000007788 liquid Substances 0.000 description 1
239000000155 melt Substances 0.000 description 1
238000012986 modification Methods 0.000 description 1
230000004048 modification Effects 0.000 description 1
UKOVZLWSUZKTRL-UHFFFAOYSA-N naphthalid Chemical compound C1=CC(C(=O)OC2)=C3C2=CC=CC3=C1 UKOVZLWSUZKTRL-UHFFFAOYSA-N 0.000 description 1
150000002825 nitriles Chemical class 0.000 description 1
230000000269 nucleophilic effect Effects 0.000 description 1
IPNPIHIZVLFAFP-UHFFFAOYSA-N phosphorus tribromide Chemical compound BrP(Br)Br IPNPIHIZVLFAFP-UHFFFAOYSA-N 0.000 description 1
229960005235 piperonyl butoxide Drugs 0.000 description 1
ZNNZYHKDIALBAK-UHFFFAOYSA-M potassium thiocyanate Chemical compound [K+].[S-]C#N ZNNZYHKDIALBAK-UHFFFAOYSA-M 0.000 description 1
229940116357 potassium thiocyanate Drugs 0.000 description 1
UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
239000000376 reactant Substances 0.000 description 1
238000010898 silica gel chromatography Methods 0.000 description 1
239000011734 sodium Substances 0.000 description 1
229910052708 sodium Inorganic materials 0.000 description 1
229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
235000017557 sodium bicarbonate Nutrition 0.000 description 1
239000012312 sodium hydride Substances 0.000 description 1
229910000104 sodium hydride Inorganic materials 0.000 description 1
229910052938 sodium sulfate Inorganic materials 0.000 description 1
235000011152 sodium sulphate Nutrition 0.000 description 1
238000003756 stirring Methods 0.000 description 1
125000001424 substituent group Chemical group 0.000 description 1
239000011593 sulfur Substances 0.000 description 1
229910052717 sulfur Inorganic materials 0.000 description 1
230000000699 topical effect Effects 0.000 description 1
239000011701 zinc Substances 0.000 description 1
229910052725 zinc Inorganic materials 0.000 description 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
- C07D237/26—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings condensed with carbocyclic rings or ring systems
- C07D237/30—Phthalazines
- C07D237/32—Phthalazines with oxygen atoms directly attached to carbon atoms of the nitrogen-containing ring
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/87—Benzo [c] furans; Hydrogenated benzo [c] furans
- C07D307/89—Benzo [c] furans; Hydrogenated benzo [c] furans with two oxygen atoms directly attached in positions 1 and 3

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Diabetes (AREA)
Medicinal Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Hematology (AREA)
Obesity (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Emergency Medicine (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Endocrinology (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Plural Heterocyclic Compounds (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Thiazole And Isothizaole Compounds (AREA)

DD88326850A 1987-06-09 1988-06-07 Herstellung von zwischenprodukten der oxophthalazinyl-essigsaeuren mit benzothiazol- oder anderen heterocyclischen seitenketten DD280323A5 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US5989987A	1987-06-09	1987-06-09

Publications (1)

Publication Number	Publication Date
DD280323A5 true DD280323A5 (de)	1990-07-04

Family

ID=22026001

Family Applications (3)

Application Number	Title	Priority Date	Filing Date
DD88326850A DD280323A5 (de)	1987-06-09	1988-06-07	Herstellung von zwischenprodukten der oxophthalazinyl-essigsaeuren mit benzothiazol- oder anderen heterocyclischen seitenketten
DD88316492A DD281600A5 (de)	1987-06-09	1988-06-07	Herstellung von oxophthalazinyl-essigsaeuren mit benzothiazol- oder anderen heterocyclischen seitenketten
DD88326849A DD280320A5 (de)	1987-06-09	1988-06-07	Herstellung von zwischenprodukten der oxophthalazinyl-essigsaeuren mit benzothiazol oder anderen heterocyclischen seitenketten

Family Applications After (2)

Application Number	Title	Priority Date	Filing Date
DD88316492A DD281600A5 (de)	1987-06-09	1988-06-07	Herstellung von oxophthalazinyl-essigsaeuren mit benzothiazol- oder anderen heterocyclischen seitenketten
DD88326849A DD280320A5 (de)	1987-06-09	1988-06-07	Herstellung von zwischenprodukten der oxophthalazinyl-essigsaeuren mit benzothiazol oder anderen heterocyclischen seitenketten

Country Status (26)

Country	Link
EP (1)	EP0295051B1 (cs)
JP (1)	JPH0676391B2 (cs)
KR (1)	KR900004698B1 (cs)
CN (1)	CN1024347C (cs)
AT (1)	ATE90347T1 (cs)
AU (1)	AU593742B2 (cs)
CA (1)	CA1321791C (cs)
CS (1)	CS274628B2 (cs)
DD (3)	DD280323A5 (cs)
DE (1)	DE3881583T2 (cs)
DK (1)	DK309988A (cs)
EG (1)	EG18613A (cs)
ES (1)	ES2040853T3 (cs)
FI (1)	FI93835C (cs)
HU (1)	HU205108B (cs)
IE (1)	IE61499B1 (cs)
IL (1)	IL86660A0 (cs)
MY (1)	MY103573A (cs)
NO (1)	NO176317C (cs)
NZ (1)	NZ224937A (cs)
PH (1)	PH25928A (cs)
PL (1)	PL157690B1 (cs)
PT (1)	PT87669B (cs)
SU (1)	SU1678208A3 (cs)
YU (1)	YU46696B (cs)
ZA (1)	ZA884075B (cs)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0322153A3 (en) *	1987-12-21	1990-08-16	Pfizer Inc.	Heterocyclic oxophtalazinyl acetic acids
WO1989006651A1 (en) *	1988-01-19	1989-07-27	Pfizer Inc.	1h-indazole-3-acetic acids as aldose reductase inhibitors
US4904782A (en) *	1988-02-29	1990-02-27	Pfizer Inc.	Process for the production of phthalazineacetic acid ester derivatives and a novel intermediate
US4954629A (en) *	1989-05-11	1990-09-04	Pfizer Inc.	Process and intermediates for the preparation of oxophthalazinyl acetic acids and analogs thereof
FR2647676A1 (fr) *	1989-06-05	1990-12-07	Union Pharma Scient Appl	Nouveaux derives de pyridazinone, leurs procedes de preparation, medicaments les contenant, utiles notamment comme inhibiteurs de l'aldose reductase
FI922308L (fi) *	1989-12-15	1992-05-21	Pfizer	Substituerade oxoftalazinylaettiks- syror och deras analoger.
US5064830A (en) *	1990-08-02	1991-11-12	Pfizer Inc.	Lowering of blood uric acid levels
WO1992003432A1 (en) *	1990-08-28	1992-03-05	Pfizer Inc.	3-(5-trifluoromethylbenzothiazol-2-ylmethyl)-4-oxo-3h-phythalazin-1-ylacetic acid monohydrate
WO1992017446A2 (en) *	1991-03-28	1992-10-15	Pfizer Inc.	Pyridazinone acetic acids aldose reductase inhibitors
FR2682108B1 (fr) *	1991-10-07	1994-01-07	Lipha	Acide 3,4-dihydro-4-oxo-3(prop-2-enyl)-1-phtalazineacetiques et derives, leurs preparations et medicaments les contenant.
DE69405193T2 (de) *	1993-10-06	1998-01-02	Sumika Fine Chemicals Co Ltd	Verfahren zur Herstellung von Alkyl-3-phthalidylidenacetat
US5700819A (en) *	1994-11-29	1997-12-23	Grelan Pharmaceutical Co., Ltd.	2-substituted benzothiazole derivatives and prophylactic and therapeutic agents for the treatment of diabetic complications
IL124236A (en) *	1997-05-05	2003-01-12	Pfizer	Pharmaceutical composition for treating or reversing diabetic cardiomyopathy comprising aldose reductase inhibitor
EP0982306A3 (en) *	1998-08-21	2000-07-05	Pfizer Products Inc.	Polymorph of zopolrestat monohydrate
SG82702A1 (en) *	1999-09-28	2001-08-21	Ebauchesfabrik Eta Ag	Timepiece including a movement mounted in a casing ring
CN116970317B (zh) *	2023-03-20	2024-06-25	安徽庆丰涂料科技有限公司	可呼吸的负离子抗菌涂料及其加工工艺

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IE47592B1 (en) *	1977-12-29	1984-05-02	Ici Ltd	Enzyme inhibitory phthalazin-4-ylacetic acid derivatives, pharmaceutical compositions thereof,and process for their manufacture
JPS5931509B2 (ja) *	1979-06-06	1984-08-02	昭和電工株式会社	３−ヒドロキシ−３−メチルフタリド又はその核置換体の製造法
IL80475A (en) *	1985-11-07	1993-01-31	Pfizer	Heterocyclic-substituted 4-oxo (or thio)-3h- phthalazinyl-acetic acid derivatives and pharmaceutical compositions containing them

1988
- 1988-06-02 JP JP63136601A patent/JPH0676391B2/ja not_active Expired - Lifetime
- 1988-06-06 PH PH37013A patent/PH25928A/en unknown
- 1988-06-06 MY MYPI88000606A patent/MY103573A/en unknown
- 1988-06-07 ES ES198888305180T patent/ES2040853T3/es not_active Expired - Lifetime
- 1988-06-07 CA CA000568775A patent/CA1321791C/en not_active Expired - Fee Related
- 1988-06-07 DD DD88326850A patent/DD280323A5/de not_active IP Right Cessation
- 1988-06-07 CS CS392488A patent/CS274628B2/cs not_active IP Right Cessation
- 1988-06-07 DE DE8888305180T patent/DE3881583T2/de not_active Expired - Fee Related
- 1988-06-07 PL PL1988272899A patent/PL157690B1/pl unknown
- 1988-06-07 EP EP88305180A patent/EP0295051B1/en not_active Expired - Lifetime
- 1988-06-07 DD DD88316492A patent/DD281600A5/de not_active IP Right Cessation
- 1988-06-07 AT AT88305180T patent/ATE90347T1/de not_active IP Right Cessation
- 1988-06-07 DD DD88326849A patent/DD280320A5/de not_active IP Right Cessation
- 1988-06-08 AU AU17491/88A patent/AU593742B2/en not_active Ceased
- 1988-06-08 FI FI882722A patent/FI93835C/fi not_active IP Right Cessation
- 1988-06-08 CN CN88103507A patent/CN1024347C/zh not_active Expired - Fee Related
- 1988-06-08 IL IL86660A patent/IL86660A0/xx not_active IP Right Cessation
- 1988-06-08 YU YU111188A patent/YU46696B/sh unknown
- 1988-06-08 ZA ZA884075A patent/ZA884075B/xx unknown
- 1988-06-08 DK DK309988A patent/DK309988A/da not_active Application Discontinuation
- 1988-06-08 NO NO882516A patent/NO176317C/no not_active IP Right Cessation
- 1988-06-08 NZ NZ224937A patent/NZ224937A/xx unknown
- 1988-06-08 IE IE171688A patent/IE61499B1/en unknown
- 1988-06-08 SU SU884355901A patent/SU1678208A3/ru active
- 1988-06-08 KR KR1019880006855A patent/KR900004698B1/ko not_active Expired
- 1988-06-08 HU HU882971A patent/HU205108B/hu not_active IP Right Cessation
- 1988-06-08 PT PT87669A patent/PT87669B/pt not_active IP Right Cessation
- 1988-06-09 EG EG320/88A patent/EG18613A/xx active

Also Published As

Publication number	Publication date
KR900004698B1 (ko)	1990-07-02
JPH0676391B2 (ja)	1994-09-28
DK309988A (da)	1988-12-10
ZA884075B (en)	1990-02-28
PL272899A1 (en)	1989-07-10
CA1321791C (en)	1993-08-31
SU1678208A3 (ru)	1991-09-15
AU1749188A (en)	1988-12-15
FI882722A0 (fi)	1988-06-08
PL157690B1 (en)	1992-06-30
NZ224937A (en)	1991-01-29
DD280320A5 (de)	1990-07-04
NO176317B (no)	1994-12-05
YU46696B (sh)	1994-04-05
KR890000476A (ko)	1989-03-14
DD281600A5 (de)	1990-08-15
IL86660A0 (en)	1988-11-30
NO882516D0 (no)	1988-06-08
HU205108B (en)	1992-03-30
CN1024347C (zh)	1994-04-27
EG18613A (en)	1993-08-30
EP0295051A3 (en)	1989-03-22
NO882516L (no)	1988-12-12
ATE90347T1 (de)	1993-06-15
IE61499B1 (en)	1994-11-02
JPS643173A (en)	1989-01-06
EP0295051B1 (en)	1993-06-09
CN88103507A (zh)	1988-12-28
DE3881583D1 (de)	1993-07-15
PT87669B (pt)	1992-09-30
NO176317C (no)	1995-03-15
EP0295051A2 (en)	1988-12-14
PT87669A (pt)	1988-07-01
DK309988D0 (da)	1988-06-08
PH25928A (en)	1991-12-19
CS392488A2 (en)	1990-08-14
DE3881583T2 (de)	1993-09-16
IE881716L (en)	1988-12-09
CS274628B2 (en)	1991-09-15
YU111188A (en)	1989-12-31
ES2040853T3 (es)	1993-11-01
MY103573A (en)	1993-08-28
FI93835B (fi)	1995-02-28
FI882722A7 (fi)	1988-12-10
FI93835C (fi)	1995-06-12
AU593742B2 (en)	1990-02-15

Legal Events

Date	Code	Title	Description
1994-04-14	NPV	Change in the person, the name or the address of the representative (addendum to changes before extension act)
1995-08-31	ENJ	Ceased due to non-payment of renewal fee

Publication	Publication Date	Title
DE69723846T2 (de)	2004-03-04	Verfahren zur Herstellung von Sildenafil
DE69434020T2 (de)	2005-09-29	Verfahren und zwischenprodukte für die herstellung von 5-[4-(benzisothiazol-3-yl)-piperazin-1-yl)ethyl]-6 chlor-1,3-dihydro-indol-2-one
DE3881583T2 (de)	1993-09-16	Herstellung von oxophthalazinylessigsaeuren mit einer benzothiazol- oder einer anderen heterocyclischen seitenkette.
EP0011142B1 (de)	1982-12-29	Pyrido (2,1-b) chinazolinon-Derivate, Verfahren zu ihrer Herstellung und sie enthaltende pharmazeutische Präparate
DE69616956T3 (de)	2014-01-30	3-Amino-2-mercaptobenzoesäure-Derivate und Verfahren zu ihrer Herstellung
EP0606065B1 (de)	1999-08-25	Verfahren zur Herstellung von Biphenylderivaten
DE2809720C2 (cs)	1992-01-16
EP0380712B1 (de)	1995-01-04	Verfahren zur Herstellung von 2,6-Dichlordiphenylaminessigsäurederivaten
DE69424095T2 (de)	2000-09-28	Verfahren zur Herstellung von 2-Cyano-4-oxo-4H-benzopyran-Verbindungen
DE3850240T2 (de)	1995-02-02	Verfahren zur Herstellung von O-Carboxyarylimidazolinone.
DE2320040A1 (de)	1974-11-07	Verfahren zur herstellung von 7acylamino-desacetoxy-cephalosporansaeureester
DE2841644C2 (cs)	1989-09-21
EP0505742A2 (de)	1992-09-30	Verfahren zur Herstellung von in 3-Stellung substituierten 4-Cyano-pyrrolverbindungen
DE4301245A1 (de)	1994-07-21	Fluor-trifluormethylbenzoesäure-Derivate
EP0299277B1 (de)	1995-10-18	Verfahren zur Herstellung von substituierten Pyridylalkylketonen
CH638516A5 (en)	1983-09-30	Process for preparing substituted aminoquinazoline derivatives
DE2624344C2 (de)	1987-03-19	Verfahren zur Herstellung von in 1-Stellung unsubstituierten 3-(2-Hydroxyäthyl)-indol-Derivaten
EP0302227B1 (de)	1993-01-13	5-Halogen-6-amino-nikotin-säurehalogenide, ihre Herstellung und ihre Verwendung
DE4426373A1 (de)	1996-02-01	3-Substituierte Chinolin-5-carbonsäurederivate und Verfahren zu ihrer Herstellung
EP0090769B1 (de)	1986-08-20	Verfahren zur Herstellung von 1,2,5,6-Tetrahydro-4H-pyrrolo(3,2,1-ij)-chinolin-4-on und neue 5-Halogen-1,2,3-(1,2-dihydropyrrolo)-4-chinolone als Zwischenprodukte zur Durchführung des Verfahrens
EP0341478A2 (de)	1989-11-15	Verfahren zur Herstellung von 2,3-Dichlor-5-acetylpyridin
CH620414A5 (cs)	1980-11-28
DE2406972B2 (de)	1978-11-23	Verfahren zur Herstellung von 5-Sulfamoylanthranilsäuren
DE3924682A1 (de)	1991-01-31	Verfahren zur herstellung von chlorierten nicotinaldehyden
DE69711397T2 (de)	2002-11-28	Herstellung von einem hydrazon-beta-ketoester durch reaktion mit einem diazoester